2010
DOI: 10.1039/c0em00238k
|View full text |Cite
|
Sign up to set email alerts
|

A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment

Abstract: Upon partial degradation of polar organic micropollutants during activated sludge treatment, transformation products (TPs) may be formed that enter the aquatic environment in the treated effluent. However, TPs are rarely considered in prospective environmental risk assessments of wastewater-relevant compound classes such as pharmaceuticals and biocides. Here, we suggest and evaluate a tiered procedure, which includes a fast initial screening step based on high resolution tandem mass spectrometry (HR-MS/MS) and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
95
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 125 publications
(102 citation statements)
references
References 35 publications
5
95
2
Order By: Relevance
“…The ability of the microbes in WWTPs to biotransform these chemicals is an area of great interest (Carballa et al ., 2004; Castiglioni et al ., 2005; Nakada et al ., 2006; Kasprzyk‐Hordern et al ., 2009). Substantial research has advanced our knowledge of pharmaceutical biotransformation pathways (Ellis et al ., 2006) and the transformation products formed during treatment (Kern et al ., 2010). However, only one study to our knowledge has linked chemical transformation data with wastewater microbial community composition and activity (Helbling et al ., 2015), and no studies to date have identified specific functions associated with biotransformation to develop predictive relationships between functional characteristics of the microbial community and pharmaceutical biotransformation pathways and extents.…”
Section: Introductionmentioning
confidence: 99%
“…The ability of the microbes in WWTPs to biotransform these chemicals is an area of great interest (Carballa et al ., 2004; Castiglioni et al ., 2005; Nakada et al ., 2006; Kasprzyk‐Hordern et al ., 2009). Substantial research has advanced our knowledge of pharmaceutical biotransformation pathways (Ellis et al ., 2006) and the transformation products formed during treatment (Kern et al ., 2010). However, only one study to our knowledge has linked chemical transformation data with wastewater microbial community composition and activity (Helbling et al ., 2015), and no studies to date have identified specific functions associated with biotransformation to develop predictive relationships between functional characteristics of the microbial community and pharmaceutical biotransformation pathways and extents.…”
Section: Introductionmentioning
confidence: 99%
“…Product ion spectra of atenolol and atenolol acid have been described in previous studies as well as the structural identification process of the transformation products [22,43]. However, to date only one biodegradation product, i.e., atenolol acid (P267), has been identified in the biodegradation of atenolol by conventional activated sludge, membrane bioreactor sludge or activated sludge from a full-scale aerobic nitrification reactor [22,44].…”
Section: Structural Elucidation Of Biodegradation Productsmentioning
confidence: 99%
“…In the tiered approach proposed by Kern et al, batch experiments with activated sludge can be used to verify the findings and to quantify transformation rates [52].…”
Section: Transformation Products (Metabolites) Formed By Human Metabomentioning
confidence: 99%
“…As UM-PPS is freely accessible and all rules applied are clearly assigned, it is the most common prediction tool in suspect screening, and many researchers have tried to evaluate and to improve its prediction power [34,[50][51][52]. The prediction rules behind UM-PPS come from the University of Minnesota Biocatalysis/ Biodegradation Database (UM-BBD) and literature [85].…”
Section: Suspect Screening -Prediction Of Transformation Productsmentioning
confidence: 99%